AUY Volume Alert - AUY 3.92 Yamana Gold $AUY Hit a high of

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
AUY Volume Alert - AUY 3.92 Yamana Gold $AUY Hit a high of 3.95 Currently 11/07/14 Last price 3.92 +0.38 +10.73% With a day low of 3.61 and a current volume of 21,219,500.

AUY Yamana Gold Recent Headline News

Most active New York Stock Exchange-traded stocks
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
KMI: 38.75 (+0.22), F: 14.17 (-0.02), GE: 26.41 (+0.05), RF: 10.16 (-0.07), ABX.TO: 13.79 (+0.82), K.TO: 2.84 (+0.30), ABX: 12.16 (+0.82), BAC: 17.36 (unch), ANR: 2.91 (+0.39), GNW: 8.41 (-0.25), YRI.TO: 4.47 (+0.44), KGC: 2.50 (+0.29), S: 4.72 (+0.03), TWTR: 40.31 (-0.53), AUY: 3.92 (+0.38)

Kinross Gold (KGC) Stock Soaring Today as Gold Prices Rise
at The Street - Fri Nov 07, 2:50PM CST
Kinross Gold (KGC) stock is rising along with the gold sector following the latest U.S. jobs data, showing a weaker than expected increase for October.
ABX: 12.16 (+0.82), KGC: 2.50 (+0.29), AUY: 3.92 (+0.38), GG: 20.02 (+1.47)

Yamana Gold (AUY) Stock Hits One-Year Low as Gold Prices Sink to Four-Year Low
at The Street - Wed Nov 05, 11:26AM CST
Shares of Yamana Gold (AUY) fell to a new 52-week low on Wednesday after gold prices continued to slump and touched a four-year low.
AUY: 3.92 (+0.38)

Which Gold Stocks Are Just Too Cheap to Ignore?
at The Street - Wed Nov 05, 5:05AM CST
Investors should be panning for gold mining stocks that have declined more than Comex gold. Here's the technical analysis.
ABX: 12.16 (+0.82), NEM: 19.19 (+0.99), AUY: 3.92 (+0.38), GG: 20.02 (+1.47)

A Morbid Halloween for 3 Gold Mining Stocks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 1:53PM CST
We highlight three gold-mining stocks that have delivered disappointing earnings results and negative earnings surprise this earnings season.
NGD: 3.89 (+0.43), AUY: 3.92 (+0.38), GG: 20.02 (+1.47)

Stock Futures Set For Weak Open; Sapient, Covance, FedEx Rising
at Investor's Business Daily - Mon Nov 03, 7:58AM CST
Stock futures stuck to narrow losses ahead of Monday's open. Dow futures were a mild 35.5 points below fair market value and steady. Nasdaq 100 futures trimmed losses to 2.3 points. S&P 500 futures' losses also narrowed, to 2.7 points. The stock...
VEEV: 28.43 (+0.69), FDX: 171.22 (-0.48), OMC: 72.71 (-0.10), SAPE: 24.67 (+0.03), GOLD: 67.33 (+2.72), AU: 9.82 (+0.79), LH: 100.52 (-2.41), AUY: 3.92 (+0.38), CVD: 100.52 (-0.58)

Downgrade Alert for Yamana Gold (AUY)
Comtex SmarTrend(R) - Mon Nov 03, 6:52AM CST
Yamana Gold (NYSE:AUY) was downgraded from Buy to Neutral at Goldman Sachs today. The stock closed yesterday at $3.98 on volume of 34.8 million shares, above average daily volume of 11.0 million. Yamana Gold (NYSE:AUY) has potential upside of 135.1% based on a current price of $3.98 and analysts' consensus price target of $9.36. The stock should find initial resistance at its 50-day moving average (MA) of $6.54 and further resistance at its 200-day MA of $8.11.
AUY: 3.92 (+0.38)

Yamana Gold (AUY) Stock Hits One-Year Low as Gold Prices Slump
at The Street - Fri Oct 31, 10:38AM CDT
Shares of Yamana Gold (AUY) hit a one-year low in morning trading Friday after gold prices sank to a four-year low.
AUY: 3.92 (+0.38)

Yamana Gold Set to Possibly Rebound After Yesterday's Selloff of 17.10%
Comtex SmarTrend(R) - Thu Oct 30, 4:20PM CDT
Yamana Gold (NYSE:AUY) traded in a range yesterday that spanned from a low of $4.42 to a high of $4.95. Yesterday, the shares fell 17.1%, which took the trading range below the 3-day low of $5.31 on volume of 37.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AUY: 3.92 (+0.38)

Look for Shares of Yamana Gold to Potentially Rebound after Yesterday's 17.10% Sell Off
Comtex SmarTrend(R) - Thu Oct 30, 4:20PM CDT
Yamana Gold (NYSE:AUY) traded in a range yesterday that spanned from a low of $4.42 to a high of $4.95. Yesterday, the shares fell 17.1%, which took the trading range below the 3-day low of $5.31 on volume of 37.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AUY: 3.92 (+0.38)

Ocwen Financial Climbs Despite Earnings Shortfall
at The Street - Thu Oct 30, 4:20PM CDT
ABIOMED, Inc. (NASDAQ:ABMD), Calix Inc (NYSE:CALX) and Ocwen Financial Corp (NYSE:OCN) are today's top-gaining billionaire stock picks. In the red this Thursday are Yamana Gold Inc. (NYSE:AUY), Wes...
ABMD: 32.13 (+0.47), CALX: 11.44 (unch), OCN: 21.17 (-0.24), AUY: 3.92 (+0.38), WSTL: 1.42 (+0.01)

Visa and Baidu are big market movers
AP - Thu Oct 30, 3:26PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
ORB: 24.24 (+0.01), EA: 40.94 (+0.14), FB: 75.60 (+0.34), AMCC: 6.46 (-0.14), ARAY: 6.85 (-0.05), GT: 25.15 (unch), BIDU: 236.54 (-0.36), V: 252.43 (+2.34), YRI.TO: 4.47 (+0.44), TEX: 28.88 (+0.21), ARCP: 8.79 (+0.15), NYT: 12.76 (-0.07), TASR: 18.52 (+0.09), X: 37.57 (+1.47), AUY: 3.92 (+0.38)

Yamana Gold (AUY) Stock Slides Today After Third-Quarter Net Loss
at The Street - Thu Oct 30, 10:13AM CDT
The Toronto-based gold miner reported a significant third-quarter net loss today, reflecting impairment charges for Brazilian mines and charges related to newly enacted Chilean tax changes.
AUY: 3.92 (+0.38)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Initiated for Voyager Therapeutics Investors

Updated Category News Views 115

Investigation Overview for Voyager Therapeutics Investors Pomerantz LLP is currently exploring possible claims on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR). This exploration arises from concerns surrounding the company’s recent announcements and operational strategies. Details of the Investigation The inquiry focuses on whether Voyager and some of...

Continue Reading
Subway's Creative Middle Seat Reward for Travelers

Updated Category News Views 132

Subway Announces Exciting Promotion for Air Travelers On January 27, a significant change is happening for travelers, especially for those who dread sitting in the middle seat of a plane. With a popular airline ending its open seating policy, millions are gearing up for assigned seating. This means that many passengers might find themselves in the middle seat, which is...

Continue Reading
Expanse Studios Unveils Innovative Games at Major Summit

Updated Category News Views 86

Expanse Studios Shines at Industry Summit Expanse Studios, a cutting-edge gaming developer and a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has made a significant impression at the recent SBC Summit Lisbon. This event attracted around 25,000 attendees, featuring a mix of gaming innovators and industry experts, all eager to explore what's next in the gaming...

Continue Reading
Unlocking Digital Preservation Skills Through New Academy

Updated Category News Views 150

Introducing the Preservica Academy for Digital Preservation Preservica Inc. has unveiled its exciting new initiative, Preservica Academy, dedicated to enhancing the skills of professionals and beginners in the realm of digital preservation. This innovative program focuses on Active Digital Preservation™, aiming to ensure the long-term accessibility and integrity of...

Continue Reading
Seritage Growth Properties Investors Alert: Class Action Lawsuit Update

Updated Category News Views 107

Notification of Class Action Lawsuit for Seritage Growth Properties Levi & Korsinsky, LLP is reaching out to inform investors of Seritage Growth Properties (NYSE: SRG) regarding an ongoing class action securities lawsuit. This case marks an important development for those affected by alleged securities fraud. Overview of the Class Action Lawsuit This lawsuit is centered...

Continue Reading